Bankrupt Pharma Co. Impel Gets OK For $17.5M Sale

By Ben Zigterman · February 1, 2024, 7:45 PM EST

Migraine-drug maker Impel Pharmaceuticals can proceed with its sale to JN Bidco LLC, which had made a $17.5 million stalking horse bid, U.S. Bankruptcy Judge Stacey G. Jernigan said at a...

To view the full article, register now.